Selected presentations of lip enlargement: clinical manifestation and differentiation.

about

Selected presentations of lip enlargement: clinical manifestation and differentiation.

Item

http://www.wikidata.org/entity/Q55315127

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Selected presentations of lip enlargement: clinical manifestation and differentiation.

@en

Selected presentations of lip enlargement: clinical manifestation and differentiation.

@nl

type

Item

label

Selected presentations of lip enlargement: clinical manifestation and differentiation.

@en

Selected presentations of lip enlargement: clinical manifestation and differentiation.

@nl

prefLabel

Selected presentations of lip enlargement: clinical manifestation and differentiation.

@en

Selected presentations of lip enlargement: clinical manifestation and differentiation.

@nl

P1476

Selected presentations of lip enlargement: clinical manifestation and differentiation.

@en

P2093

Bartłomiej Kamiński

http://www.w3.org/2001/XMLSchema#string

Henryk Witmanowski

http://www.w3.org/2001/XMLSchema#string

Jerzy Sokalski

http://www.w3.org/2001/XMLSchema#string

Katarzyna J Błochowiak

http://www.w3.org/2001/XMLSchema#string

P2860

Cheilitis granulomatosa

Severe cutaneous adverse drug reactions.

Erysipelas, a large retrospective study of aetiology and clinical presentation.

Orofacial granulomatosis presenting as persistent lip swelling: review of 6 new cases.

Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea.

Ascher syndrome: Review of literature and case report.

The Melkersson-Rosenthal syndrome: a retrospective study of biopsied cases.

Oral mucocele: Review of literature and a case report.

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis--A Comprehensive Review and Guide to Therapy. I. Systemic Disease.

Adverse drug reactions and organ damage: The skin.

P304

18-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/ADA.2018.73160

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29599668

http://www.w3.org/2001/XMLSchema#string

P932

5872243

http://www.w3.org/2001/XMLSchema#string